Comparative analysis and integrative classification of NCI60 cell lines and primary tumors using gene expression profiling data
2006

Comparative Analysis of NCI60 Cell Lines and Primary Tumors

Sample size: 59 publication Evidence: moderate

Author Information

Author(s): Wang Huixia, Huang Shuguang, Shou Jianyong, Su Eric W, Onyia Jude E, Liao Birong, Li Shuyu

Primary Institution: Lilly Research Laboratories, Eli Lilly and Company

Hypothesis

Do NCI60 cell lines accurately represent their tumor tissues of origin?

Conclusion

Most NCI60 cell lines are representative of their corresponding tumor types, providing suitable models for cancer research.

Supporting Evidence

  • 51 of 59 NCI60 cell lines represent their presumed tumors of origin.
  • 6 of 7 non-small cell lung cancer cell lines were classified as lung adenocarcinomas.
  • All colorectal cancer, leukemia, melanoma, and ovarian cancer cell lines matched their tumor origins.

Takeaway

This study looked at cancer cell lines and found that most of them are like the tumors they come from, which helps scientists study cancer better.

Methodology

Gene expression profiles of NCI60 cell lines were compared to those of primary tumors using Pearson's correlation coefficients.

Potential Biases

Potential misclassification of cell lines due to genomic instability and cross-contamination.

Limitations

Gene expression profiles in vitro may not reflect those in vivo, and classification predictions are not experimentally validated.

Participant Demographics

NCI60 cell lines derived from various cancer types including breast, lung, and leukemia.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2164-7-166

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication